Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Moorfields Pharmaceuticals

Moorfields Pharmaceuticals is the manufacturing arm of Moorfields Eye Hospital NHS Foundation Trust. We produce nearly 100 ophthalmic specials and have a growing portfolio of branded licensed products. Moorfields Eye Hospital has provided products in response to clinical needs for over 50 years, from just a handful of pharmacists within the hospital, we now employ more than 75 people.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Moorfields Pharmaceuticals
25 Provost Street, London, N1 7NH, United Kingdom
+44 (0)20 7684 9090
Contact Moorfields Pharmaceuticals
Website

 Latest Content from PMHub 

Virtualizing Healthcare with Human-Centric Technology

Videos and Podcasts | April 14, 2022 | Impetus Digital

Dr. Patrick Carroll, Chief Medical Officer at Vida Health, discusses the importance of using a “whole health” approach to chronic disease management, how and why the human connection with a...

Onyx Health Joins Forces with Rare Disease Specialists Actigen

Press Releases | April 14, 2022 | Onyx Health

Onyx Health will be working with Actigen to raise awareness of their innovative clinical trial work in rare diseases and the need to develop new treatment solutions.

From Vision to Action: Medical Affairs’ Time to Lead is Now – Key Themes and Takeaways From the 2022 Medical Affairs Professional Society (MAPS) Global Annual Meeting

Press Releases | April 14, 2022 | Nucleus Global

Nucleus Global’s Luis Perez shares his thoughts on this year’s meeting

Importance of Diversity in Pharma and Clinical Trials

White Papers and Resources | April 13, 2022 | Impetus Digital

No matter which sector you work in, diversity and inclusion are must-haves!

Launch excellence

Press Releases | April 12, 2022 | Lucid Group Communications Limited

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Case Study: Reducing Travel-Related Emissions and Costs Through Virtual Events

White Papers and Resources | April 11, 2022 | Impetus Digital

In early 2021, due to COVID-19-related safety concerns and travel and social distancing restrictions, our client needed help to “virtualize” their nationwide, multi-day, multi-business unit internal event with 375 attendees....

Meet The Lucid Group Talent Team

Videos and Podcasts | April 11, 2022 | Lucid Group Communications Limited

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Celebrating the new UK rare diseases framework

White Papers and Resources | April 8, 2022 | Dice Medical Communications

Dice's take on the importance of the rare diseases framework

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Videos and Podcasts | April 8, 2022 | Impetus Digital

A version of this article was previously published on Pharmaphorum.There is not a single industry that has been left untouched by COVID-19. While the effects of the pandemic have been devastating...

Data-Driven Approaches for Neurorecovery

Videos and Podcasts | April 7, 2022 | Impetus Digital

Yotam Drechsler (Co-founder/CEO) and Yaron Segal (Co-founder/CINO) from BrainQ Technologies dives into the roles of Brain-Computer Interface technologies and electrophysiology measurements in aiding neurorecovery, the role of AI and machine...